Wexford Capital’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$432K Buy
12,000
+2,000
+20% +$72K 0.12% 115
2025
Q1
$394K Sell
10,000
-4,000
-29% -$158K 0.1% 133
2024
Q4
$421K Buy
+14,000
New +$421K 0.07% 112
2013
Q4
Sell
-30,000
Closed -$151K 267
2013
Q3
$151K Sell
30,000
-10,000
-25% -$50.3K 0.01% 193
2013
Q2
$256K Buy
+40,000
New +$256K 0.02% 160